Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

1.

L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer.

Sakata T, Ferdous G, Tsuruta T, Satoh T, Baba S, Muto T, Ueno A, Kanai Y, Endou H, Okayasu I.

Pathol Int. 2009 Jan;59(1):7-18. doi: 10.1111/j.1440-1827.2008.02319.x.

PMID:
19121087
[PubMed - indexed for MEDLINE]
2.

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.

Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Histopathology. 2009 Jun;54(7):804-13. doi: 10.1111/j.1365-2559.2009.03300.x.

PMID:
19635099
[PubMed - indexed for MEDLINE]
3.

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Nakajima T, Mori M.

Lung Cancer. 2009 Oct;66(1):120-6. doi: 10.1016/j.lungcan.2008.12.015. Epub 2009 Jan 26.

PMID:
19171406
[PubMed - indexed for MEDLINE]
4.

High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.

Ichinoe M, Mikami T, Yoshida T, Igawa I, Tsuruta T, Nakada N, Anzai N, Suzuki Y, Endou H, Okayasu I.

Pathol Int. 2011 May;61(5):281-9. doi: 10.1111/j.1440-1827.2011.02650.x. Epub 2011 Mar 17.

PMID:
21501294
[PubMed - indexed for MEDLINE]
5.

Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.

Okubo S, Zhen HN, Kawai N, Nishiyama Y, Haba R, Tamiya T.

J Neurooncol. 2010 Sep;99(2):217-25. doi: 10.1007/s11060-010-0117-9. Epub 2010 Jan 21.

PMID:
20091333
[PubMed - indexed for MEDLINE]
6.

Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Iijima H, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Pathol Res Pract. 2008;204(8):553-61. doi: 10.1016/j.prp.2008.02.003. Epub 2008 Apr 28.

PMID:
18440724
[PubMed - indexed for MEDLINE]
7.

Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

Fleischmann A, Schlomm T, Huland H, Köllermann J, Simon P, Mirlacher M, Salomon G, Chun FH, Steuber T, Simon R, Sauter G, Graefen M, Erbersdobler A.

Clin Cancer Res. 2008 Dec 1;14(23):7838-42. doi: 10.1158/1078-0432.CCR-08-1432.

PMID:
19047112
[PubMed - indexed for MEDLINE]
Free Article
8.

High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas.

Yanagisawa N, Ichinoe M, Mikami T, Nakada N, Hana K, Koizumi W, Endou H, Okayasu I.

J Clin Pathol. 2012 Nov;65(11):1019-23. doi: 10.1136/jclinpath-2012-200826. Epub 2012 Jul 19.

PMID:
22813728
[PubMed - indexed for MEDLINE]
9.

L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

J Surg Oncol. 2009 Jun 1;99(7):433-8. doi: 10.1002/jso.21277.

PMID:
19347882
[PubMed - indexed for MEDLINE]
10.

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.

Zellweger T, Günther S, Zlobec I, Savic S, Sauter G, Moch H, Mattarelli G, Eichenberger T, Curschellas E, Rüfenacht H, Bachmann A, Gasser TC, Mihatsch MJ, Bubendorf L.

Int J Cancer. 2009 May 1;124(9):2116-23. doi: 10.1002/ijc.24174.

PMID:
19117060
[PubMed - indexed for MEDLINE]
11.

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Cancer Sci. 2008 Dec;99(12):2380-6. doi: 10.1111/j.1349-7006.2008.00969.x. Epub 2008 Nov 17.

PMID:
19018776
[PubMed - indexed for MEDLINE]
12.

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Cancer Sci. 2009 Feb;100(2):248-54. doi: 10.1111/j.1349-7006.2008.01029.x.

PMID:
19068093
[PubMed - indexed for MEDLINE]
13.

Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.

Takayama H, Nonomura N, Nishimura K, Oka D, Shiba M, Nakai Y, Nakayama M, Tsujimura A, Aozasa K, Okuyama A.

BJU Int. 2009 Feb;103(4):470-4. doi: 10.1111/j.1464-410X.2008.08013.x. Epub 2008 Sep 3.

PMID:
18778349
[PubMed - indexed for MEDLINE]
14.

L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.

Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K, Matsuo H, Kanai Y, Endou H.

Int J Cancer. 2006 Aug 1;119(3):484-92.

PMID:
16496379
[PubMed - indexed for MEDLINE]
15.

Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value.

Bantis A, Giannopoulos A, Gonidi M, Liossi A, Aggelonidou E, Petrakakou E, Athanassiades P, Athanassiadou P.

Cytopathology. 2004 Feb;15(1):25-31.

PMID:
14748788
[PubMed - indexed for MEDLINE]
16.

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.

Toyoda M, Kaira K, Ohshima Y, Ishioka NS, Shino M, Sakakura K, Takayasu Y, Takahashi K, Tominaga H, Oriuchi N, Nagamori S, Kanai Y, Oyama T, Chikamatsu K.

Br J Cancer. 2014 May 13;110(10):2506-13. doi: 10.1038/bjc.2014.178. Epub 2014 Apr 24.

PMID:
24762957
[PubMed - indexed for MEDLINE]
17.

L-type amino acid transporter 1 expression is highly correlated with Gleason score in prostate cancer.

Segawa A, Nagamori S, Kanai Y, Masawa N, Oyama T.

Mol Clin Oncol. 2013 Mar;1(2):274-280. Epub 2012 Dec 20.

PMID:
24649160
[PubMed]
Free PMC Article
18.

CD147 expression indicates unfavourable prognosis in prostate cancer.

Han ZD, Bi XC, Qin WJ, He HC, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Chen ZN, Zhong WD.

Pathol Oncol Res. 2009 Sep;15(3):369-74. doi: 10.1007/s12253-008-9131-z. Epub .

PMID:
19048397
[PubMed - indexed for MEDLINE]
19.

Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis.

Furuya M, Horiguchi J, Nakajima H, Kanai Y, Oyama T.

Cancer Sci. 2012 Feb;103(2):382-9. doi: 10.1111/j.1349-7006.2011.02151.x. Epub 2011 Dec 15.

PMID:
22077314
[PubMed - indexed for MEDLINE]
20.

Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.

Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M.

Neurosurgery. 2008 Feb;62(2):493-503; discussion 503-4. doi: 10.1227/01.neu.0000316018.51292.19.

PMID:
18382329
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk